Publication | Closed Access

Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway

Tumor BiologyMicrotubule InhibitorOncologyMedicineHepatocellular Carcinoma CellsPathologyCancer Cell BiologyAnti-cancer AgentCombretastatin A-1 PhosphateCancer BiologyCell BiologyCancer Research